Clinical trial
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following…
NCT00405327 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00405327 |
|---|---|
| Title | A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation |
| Official title | A Pilot Study of Tumor Lysate-pulsed Dendritic Cell Vaccine for Immune Augmentation for High-risk Solid Tumor Patients Following Autologous Stem Cell Transplantation |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Neuroblastoma, Wilm's Tumor |
| Intervention type | Biological, Other |
| Interventions | Tumor lysate-pulsed dendritic cell (DC) vaccine, Hematopoietic stem cell transplantation (HSCT) |
| Enrollment | 16 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Nov 30, 2006 |
| Last update posted | Nov 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: